Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role

By AHRMM

Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.

Related Resources

Podcasts
Learn the best practices of setting PAR levels and what you need to know to ensure you have the proper stock.
White Papers
Healthcare expenses continue to rise and yet hospitals are realizing consistently shrinking margins.
AHRMM What's New
Begin the year with a fresh organizational outlook using AHRMM’s Policies and Procedures Manual for the Health Care Supply Chain, 2nd Edition.…
AHRMM What's New
The fundamentals of health care supply chain management are the glue that holds the entire health care organization together. Whether you are new or…
Letter/Comment
The AHRMM LUC members submitted public comments and recommendations at the FDA's November 2020 meeting related to the need to include the UDI in the…
Guides/Reports
Building UDI into Longitudinal Data for Medical Device Evaluation (BUILD) Point of Care Capture of UDI for Implantable Devices final summary report…